{"hands_on_practices": [{"introduction": "The first step in phylodynamics is learning to \"read\" the stories embedded in a phylogenetic tree. These trees are not just diagrams of relatedness; they are historical records of evolutionary events. This exercise explores a foundational concept: how a specific event, such as the emergence of a drug-resistance mutation, leaves a distinct signature on the shape of a phylogeny. By working through this classic public health scenario, you will learn to connect an evolutionary hypothesis—a single origin of resistance—to a specific, testable pattern known as a monophyletic group or clade [@problem_id:1953611].", "problem": "In a public health investigation, scientists are tracking the evolution of a novel, rapidly mutating RNA virus. A powerful new antiviral drug has been deployed to treat infected patients. After several months, cases of drug resistance begin to appear. Genetic sequencing of viral samples from a large cohort of patients reveals both drug-sensitive and drug-resistant viral strains. A key hypothesis from the epidemiology team is that the specific genetic mutation conferring drug resistance arose exactly once in a single patient and subsequently spread to other individuals via transmission.\n\nAssuming this single-origin hypothesis is correct, if the scientists construct a phylogenetic tree from the sequences of all sampled viruses (both resistant and sensitive), which of the following patterns would they most likely observe?\n\nA. The resistant strains will form a monophyletic group (a clade).\n\nB. The resistant strains will be scattered randomly throughout the tree, intermingled with sensitive strains.\n\nC. The resistant strains will only be found at the tips of the phylogenetic tree, forming a paraphyletic group.\n\nD. The phylogenetic tree will show two distinct clades branching from the root, one containing all resistant strains and the other containing all sensitive strains.\n\nE. The resistant strains will cluster together, but they will not share a single most recent common ancestor that is unique to them.", "solution": "The problem asks us to predict the pattern of drug-resistant viral strains on a phylogenetic tree, given the crucial information that the resistance mutation occurred only once.\n\nFirst, let's understand what a phylogenetic tree represents. A phylogenetic tree is a diagram that depicts the evolutionary relationships among a group of organisms or, in this case, viruses. The branching pattern illustrates how different lineages diverged from common ancestors over time. The root of the tree represents the most recent common ancestor of all entities in the tree, and the tips (or leaves) represent the individual sampled viruses.\n\nThe core of the problem lies in the \"single-origin hypothesis.\" This means that a specific mutation conferring drug resistance arose in the viral population of a single patient at a single point in time. This mutated virus then replicated, and its descendants were passed on to other patients through transmission.\n\nLet's trace the implications of this event on the evolutionary history:\n1.  Before the mutation event, all viruses in the population were drug-sensitive. These ancestral lineages form the \"backbone\" and many of the branches of the phylogenetic tree.\n2.  At one specific point on one of these evolving lineages, the resistance mutation occurs. This point corresponds to an internal node (a common ancestor) on the future phylogenetic tree.\n3.  All viruses that descend from this specific ancestor will inherit the resistance mutation.\n4.  Therefore, the original virus with the mutation and all of its descendants form a distinct lineage of resistant viruses.\n\nNow, let's relate this to phylogenetic terminology. A group that consists of a common ancestor and all of its descendants is called a **monophyletic group**, or a **clade**. Since all the resistant viruses in this scenario share a single common ancestor (the first virus to have the mutation) and this ancestor is unique to them (in the sense that its other relatives, like its sister lineages, are not part of the resistant group), the resistant viruses will form a single, distinct clade on the tree.\n\nLet's analyze the given options based on this understanding:\n\nA. **The resistant strains will form a monophyletic group (a clade).** This is the correct description. The single mutational event creates a single ancestral resistant virus. All subsequent viruses in the transmission chain originating from this event are its descendants. This group, containing the common ancestor and all its descendants, is by definition a monophyle or clade.\n\nB. **The resistant strains will be scattered randomly throughout the tree, intermingled with sensitive strains.** This pattern would be expected if drug resistance emerged independently multiple times in different viral lineages. This phenomenon is known as convergent evolution. It directly contradicts the single-origin hypothesis.\n\nC. **The resistant strains will only be found at the tips of the phylogenetic tree, forming a paraphyletic group.** A paraphyletic group includes a common ancestor but not all of its descendants. The single-origin scenario implies all descendants will carry the trait, not just some of them. While resistant strains are indeed found at the tips of their respective branches, stating they form a paraphyletic group is incorrect and the description is incomplete as it misses the core grouping principle.\n\nD. **The phylogenetic tree will show two distinct clades branching from the root, one containing all resistant strains and the other containing all sensitive strains.** This would imply that the resistance mutation occurred at the very beginning of the outbreak, right at the first common ancestor of all sampled viruses. The problem states that resistance appeared \"after several months\" of the drug's deployment, meaning the mutation happened well after the initial outbreak began, within an already established and diverse viral population.\n\nE. **The resistant strains will cluster together, but they will not share a single most recent common ancestor that is unique to them.** This describes a polyphyletic group, which would arise if the resistant trait appeared in several different lineages that do not share an immediate common ancestor (i.e., convergent evolution), but we incorrectly group them based on the trait. This again contradicts the single-origin hypothesis.\n\nTherefore, the only pattern consistent with a single origin for the drug resistance trait is that all resistant viruses will form a single monophyletic group (a clade).", "answer": "$$\\boxed{A}$$", "id": "1953611"}, {"introduction": "Before we can confidently interpret a phylogenetic tree, we must ensure the data used to build it is both informative and reliable. This practice delves into the critical pre-analysis step of assessing the quality of your sequence alignment. You will explore two key concepts: the presence of a clear phylogenetic signal and the distorting effect of substitution saturation [@problem_id:1953556]. By calculating a hypothetical quality index from simulated assessment data, you will gain hands-on experience in quantifying data suitability, a crucial skill for any robust evolutionary analysis.", "problem": "An evolutionary biologist is studying the rapid diversification of a novel retrovirus by analyzing the sequence of its hypervariable `env` gene, obtained from 100 infected individuals. To ensure the multiple sequence alignment contains a reliable phylogenetic signal before constructing an evolutionary tree, the biologist performs two computational assessments.\n\n**Assessment 1: Likelihood-Mapping Analysis**\nThe phylogenetic information content of the alignment is evaluated by analyzing all possible quartets of sequences. The results of this analysis are as follows:\n- 78.5% of the quartets map to the corners of the barycentric plot, which corresponds to fully resolved, tree-like phylogenetic relationships.\n- 15.0% of the quartets map to the central region of the plot, indicating unresolved, star-like evolutionary patterns.\n- The remaining quartets map to the side regions, which suggests conflicting phylogenetic signals.\n\n**Assessment 2: Substitution Saturation Test**\nThe potential for substitution saturation is examined by plotting the number of observed transitions ($N_{Ts}$) against the genetic distance ($d$), estimated using the Kimura 2-parameter model. The relationship shows evidence of non-linearity, characteristic of saturation. For the purpose of quantification, the data is approximated by two linear regimes:\n- For pairs of sequences with small genetic distances ($d  0.05$), the slope of the best-fit line for $N_{Ts}$ versus $d$ is found to be $m_{Ts, \\text{short}} = 85.4$.\n- When considering the entire dataset across all genetic distances, the slope of the best-fit line for $N_{Ts}$ versus $d$ is $m_{Ts, \\text{full}} = 34.2$.\n\nTo synthesize these findings into a single metric, the biologist defines a custom \"Phylogenetic Signal Quality Index\" (PSQI). The PSQI is calculated as the product of two components: a likelihood-mapping quality score ($Q_{LM}$) and a saturation resistance score ($Q_{Sat}$).\n- The score $Q_{LM}$ is defined as the ratio of the fraction of quartets supporting a clear, tree-like structure to the total fraction of quartets that do not (i.e., those indicating star-like or conflicting signals).\n- The score $Q_{Sat}$ is defined as the ratio of the slope of the transition-distance plot over the full data range ($m_{Ts, \\text{full}}$) to the slope over the short-distance range ($m_{Ts, \\text{short}}$).\n\nCalculate the value of the PSQI for this `env` gene alignment. Round your final answer to three significant figures.", "solution": "The objective is to calculate the Phylogenetic Signal Quality Index (PSQI), which is defined as the product of the likelihood-mapping quality score ($Q_{LM}$) and the saturation resistance score ($Q_{Sat}$).\n$$PSQI = Q_{LM} \\times Q_{Sat}$$\n\nFirst, we calculate the likelihood-mapping quality score, $Q_{LM}$. This score is the ratio of the fraction of quartets supporting a tree-like structure to the fraction that do not.\n\nFrom the problem statement, the fraction of quartets supporting a tree-like structure (mapping to the corners) is given as $f_{\\text{tree-like}} = 78.5\\% = 0.785$.\n\nThe quartets that do not support a tree-like structure are those that map to the central region (star-like) or the side regions (conflicting).\nThe fraction mapping to the central region is $f_{\\text{star-like}} = 15.0\\% = 0.150$.\nThe fraction mapping to the side regions is the remainder of the total:\n$$f_{\\text{conflicting}} = 100\\% - f_{\\text{tree-like}} - f_{\\text{star-like}} = 100\\% - 78.5\\% - 15.0\\% = 6.5\\% = 0.065$$\nThe total fraction of quartets not supporting a tree-like structure is the sum of the star-like and conflicting fractions:\n$$f_{\\text{non-tree-like}} = f_{\\text{star-like}} + f_{\\text{conflicting}} = 0.150 + 0.065 = 0.215$$\nNow we can compute $Q_{LM}$:\n$$Q_{LM} = \\frac{f_{\\text{tree-like}}}{f_{\\text{non-tree-like}}} = \\frac{0.785}{0.215}$$\n\nNext, we calculate the saturation resistance score, $Q_{Sat}$. This score is defined as the ratio of the slope of the transition-distance plot over the full data range ($m_{Ts, \\text{full}}$) to the slope over the short-distance range ($m_{Ts, \\text{short}}$).\nThe problem provides these values:\n$m_{Ts, \\text{full}} = 34.2$\n$m_{Ts, \\text{short}} = 85.4$\nSo, $Q_{Sat}$ is:\n$$Q_{Sat} = \\frac{m_{Ts, \\text{full}}}{m_{Ts, \\text{short}}} = \\frac{34.2}{85.4}$$\n\nFinally, we combine these two scores to find the PSQI:\n$$PSQI = Q_{LM} \\times Q_{Sat} = \\left( \\frac{0.785}{0.215} \\right) \\times \\left( \\frac{34.2}{85.4} \\right)$$\nLet's evaluate the expression:\n$$PSQI \\approx (3.65116) \\times (0.4)$$\n$$PSQI \\approx 1.460464$$\n\nThe problem asks to round the final answer to three significant figures. The first three significant figures are 1, 4, and 6. The fourth digit is 0, so we round down.\n$$PSQI \\approx 1.46$$", "answer": "$$\\boxed{1.46}$$", "id": "1953556"}, {"introduction": "The true power of phylodynamics lies in its ability to transform phylogenetic trees into quantitative tools for testing epidemiological hypotheses. This advanced exercise introduces you to the logic of model-based inference using the birth-death process, a cornerstone of the field. You'll work directly with the mathematical framework used to assess whether a public health intervention successfully reduced a virus's transmission rate, $\\lambda$. By deriving the difference in log-likelihood between a simple model and one that accounts for the intervention, you will see precisely how phylogenies provide evidence for changes in epidemic dynamics [@problem_id:1953536].", "problem": "In the field of phylodynamics, researchers use virus genetic sequences to reconstruct phylogenetic trees, which serve as a record of the pathogen's transmission history. These trees can be analyzed using statistical models, such as the birth-death process, to infer key epidemiological parameters.\n\nConsider a simplified birth-death model for an epidemic. In this model, 'birth' corresponds to a viral transmission event, occurring at a rate $\\lambda$, and 'death' represents the removal of an infected individual from the infectious pool (e.g., through recovery or death), occurring at a rate $\\mu$. Additionally, infected individuals are sampled for sequencing at a rate $\\psi$, and these samples appear as the tips of the reconstructed phylogenetic tree.\n\nFor a reconstructed phylogeny, the log-likelihood, $\\ln L$, under a model with a potentially time-varying transmission rate $\\lambda(t)$ and constant rates $\\mu$ and $\\psi$, is given by:\n$$ \\ln L = \\sum_{i=1}^{N} \\ln(\\lambda(\\tau_i)) - \\int_{0}^{T_{end}} (\\lambda(t) + \\mu + \\psi) k(t) dt $$\nHere, $N$ is the total number of transmission events (internal nodes of the tree) occurring at times $\\tau_i$, $T_{end}$ is the time of the most recent sample, and $k(t)$ is the number of co-circulating viral lineages at time $t$. The integral term can be recognized as involving the total branch length of the tree.\n\nSuppose a major public health intervention was implemented at time $t_{int}$. To assess its effectiveness, we compare two competing models for the transmission rate:\n1.  **Null Model ($M_0$):** A constant transmission rate, $\\lambda(t) = \\lambda_0$.\n2.  **Alternative Model ($M_1$):** A piecewise-constant transmission rate, with $\\lambda(t) = \\lambda_1$ for $t  t_{int}$ and $\\lambda(t) = \\lambda_2$ for $t \\geq t_{int}$.\n\nFrom a reconstructed viral phylogeny, the following summary statistics have been extracted:\n-   Number of transmission events before $t_{int}$: $N_1$\n-   Number of transmission events at or after $t_{int}$: $N_2$\n-   Total branch duration (lineage-years) before $t_{int}$: $L_1 = \\int_0^{t_{int}} k(t) dt$\n-   Total branch duration (lineage-years) at or after $t_{int}$: $L_2 = \\int_{t_{int}}^{T_{end}} k(t) dt$\n\nThe Maximum Likelihood Estimates (MLEs) for the transmission rates, which maximize the log-likelihood for each model, are given as:\n-   For $M_0$: $\\hat{\\lambda}_0 = \\frac{N_1 + N_2}{L_1 + L_2}$\n-   For $M_1$: $\\hat{\\lambda}_1 = \\frac{N_1}{L_1}$ and $\\hat{\\lambda}_2 = \\frac{N_2}{L_2}$\n\nYour task is to calculate the difference between the maximum log-likelihood of the alternative model and the null model. Let $\\hat{L}_0$ and $\\hat{L}_1$ be the likelihoods for models $M_0$ and $M_1$ respectively, evaluated at their corresponding MLEs.\n\nDetermine the analytical expression for $\\Delta \\ln L = \\ln \\hat{L}_1 - \\ln \\hat{L}_0$ in terms of $N_1$, $N_2$, $L_1$, and $L_2$.", "solution": "We start from the general log-likelihood for a reconstructed phylogeny under a birth-death model with possibly time-varying transmission rate,\n$$\n\\ln L = \\sum_{i=1}^{N} \\ln(\\lambda(\\tau_{i})) - \\int_{0}^{T_{end}} \\left(\\lambda(t) + \\mu + \\psi\\right) k(t) \\, dt.\n$$\nSplit time at $t_{int}$ and use the definitions $N_{1}$, $N_{2}$, $L_{1}=\\int_{0}^{t_{int}} k(t)\\,dt$, and $L_{2}=\\int_{t_{int}}^{T_{end}} k(t)\\,dt$.\n\nUnder the null model $M_{0}$ with $\\lambda(t)=\\lambda_{0}$, the log-likelihood is\n$$\n\\ln L_{0}(\\lambda_{0}) = (N_{1}+N_{2}) \\ln \\lambda_{0} - \\lambda_{0}(L_{1}+L_{2}) - (\\mu+\\psi)(L_{1}+L_{2}).\n$$\nEvaluating at the MLE $\\hat{\\lambda}_{0}=\\frac{N_{1}+N_{2}}{L_{1}+L_{2}}$ yields\n$$\n\\ln \\hat{L}_{0} = (N_{1}+N_{2}) \\ln\\!\\left(\\frac{N_{1}+N_{2}}{L_{1}+L_{2}}\\right) - \\frac{N_{1}+N_{2}}{L_{1}+L_{2}}(L_{1}+L_{2}) - (\\mu+\\psi)(L_{1}+L_{2}),\n$$\nwhich simplifies to\n$$\n\\ln \\hat{L}_{0} = (N_{1}+N_{2}) \\ln\\!\\left(\\frac{N_{1}+N_{2}}{L_{1}+L_{2}}\\right) - (N_{1}+N_{2}) - (\\mu+\\psi)(L_{1}+L_{2}).\n$$\n\nUnder the alternative model $M_{1}$ with $\\lambda(t)=\\lambda_{1}$ for $tt_{int}$ and $\\lambda(t)=\\lambda_{2}$ for $t \\geq t_{int}$, the log-likelihood is\n$$\n\\ln L_{1}(\\lambda_{1},\\lambda_{2}) = N_{1} \\ln \\lambda_{1} + N_{2} \\ln \\lambda_{2} - \\lambda_{1} L_{1} - \\lambda_{2} L_{2} - (\\mu+\\psi)(L_{1}+L_{2}).\n$$\nEvaluating at the MLEs $\\hat{\\lambda}_{1}=\\frac{N_{1}}{L_{1}}$ and $\\hat{\\lambda}_{2}=\\frac{N_{2}}{L_{2}}$ gives\n$$\n\\ln \\hat{L}_{1} = N_{1} \\ln\\!\\left(\\frac{N_{1}}{L_{1}}\\right) - \\frac{N_{1}}{L_{1}} L_{1} + N_{2} \\ln\\!\\left(\\frac{N_{2}}{L_{2}}\\right) - \\frac{N_{2}}{L_{2}} L_{2} - (\\mu+\\psi)(L_{1}+L_{2}),\n$$\nhence\n$$\n\\ln \\hat{L}_{1} = N_{1} \\ln\\!\\left(\\frac{N_{1}}{L_{1}}\\right) - N_{1} + N_{2} \\ln\\!\\left(\\frac{N_{2}}{L_{2}}\\right) - N_{2} - (\\mu+\\psi)(L_{1}+L_{2}).\n$$\n\nThe difference in maximized log-likelihoods is\n$$\n\\Delta \\ln L \\equiv \\ln \\hat{L}_{1} - \\ln \\hat{L}_{0}.\n$$\nSubtracting the expressions, the common term $-(\\mu+\\psi)(L_{1}+L_{2})$ cancels, and the linear terms in $N_{1}+N_{2}$ also cancel:\n$$\n\\Delta \\ln L = \\left[N_{1} \\ln\\!\\left(\\frac{N_{1}}{L_{1}}\\right) + N_{2} \\ln\\!\\left(\\frac{N_{2}}{L_{2}}\\right)\\right] - (N_{1}+N_{2}) \\ln\\!\\left(\\frac{N_{1}+N_{2}}{L_{1}+L_{2}}\\right).\n$$\nThis expression depends only on $N_{1}$, $N_{2}$, $L_{1}$, and $L_{2}$, as required.", "answer": "$$\\boxed{N_{1}\\ln\\!\\left(\\frac{N_{1}}{L_{1}}\\right)+N_{2}\\ln\\!\\left(\\frac{N_{2}}{L_{2}}\\right)-(N_{1}+N_{2})\\ln\\!\\left(\\frac{N_{1}+N_{2}}{L_{1}+L_{2}}\\right)}$$", "id": "1953536"}]}